Gonzalez-Angulo, Ana Maria
Brigham and Women's Hospital · Beth Israel Deaconess Medical Center · Harvard University · Dana-Farber Cancer Institute
7 papers on CoChatORCID 0000-0002-9816-2707
Most cited papers
- Verified
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Liedtke, C., Mazouni, C., Hess, K. R., André, F., Tordai, A., Mejia, J. A., Symmans, W. F., Gonzalez-Angulo, A. M., Hennessy, B., Green, M., et al. (2008) · Journal of Clinical Oncology
Breast Cancer Treatment StudiesBreast Lesions and Carcinomas
Cited by 2,892
- Verified
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Berns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell
PI3K/AKT/mTOR signaling in cancerHER2/EGFR in Cancer Research
Cited by 1,627
- Verified
An integrative genomic and proteomic analysis of pik3ca, pten, and akt mutations in breast cancer.
Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W.-L., Davies, M., Carey, M., Hu, Z., Guan, Y., Sahin, A., et al. (2008) · Cancer Research
PI3K/AKT/mTOR signaling in cancerBreast Cancer Treatment Studies
Cited by 1,054
- Verified
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology
Drug Transport and Resistance MechanismsBreast Cancer Treatment Studies
Cited by 904
- Verified
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology
Metabolism, Diabetes, and CancerBreast Cancer Treatment Studies
Cited by 880
- Verified
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
Jeselsohn, R., Yelensky, R., Buchwalter, G., Frampton, G., Meric-Bernstam, F., Gonzalez-Angulo, A. M., Ferrer-Lozano, J., Perez-Fidalgo, J. A., Cristofanilli, M., Gómez, H., et al. (2014) · Clinical Cancer Research
Estrogen and related hormone effectsAdvanced Breast Cancer Therapies
Cited by 674
- Verified
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Mittendorf, E. A., Wu, Y., Scaltriti, M., Meric-Bernstam, F., Hunt, K. K., Dawood, S., Esteva, F. J., Buzdar, A. U., Chen, H., Eksambi, S., et al. (2009) · Clinical Cancer Research
HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies
Cited by 330
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free